MelindaGPaulyMD
Pediatric Hematology & Oncology • Atlanta, GAPediatric Hematologic Oncology
Assistant Professor, Pediatrics, Emory University School of Medicine Medical Director of Oncology, Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta
Dr. Pauly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5461 Meridian Marks Rd
Ste 400
Atlanta, GA 30342Phone+1 404-785-5437- Is this information wrong?
Education & Training
Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2009 - 2012
University of Alabama Medical CenterResidency, Pediatrics, 2005 - 2008
Medical College of Georgia at Augusta UniversityClass of 2005
Certifications & Licensure
GA State Medical License 2010 - 2025
AL State Medical License Active through 2009- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
- Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia Start of enrollment: 2015 Dec 01
Publications & Presentations
PubMed
- Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemi...Verma, A., Chi, Y., Malvar, J., Lamble, A., Chaudhury, S., Agarwal, A., Li, H., Liang, G., Leong, R., Brown, P., Kaplan, J., Schafer, E., Slone, T., Pauly, M., Chang, ...> ;Cancers. 2024 Jan 24
- Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation Rescues Marrow Failure From Acute Leukemia Therapy in a Patient With Previously Undiagnosed Ligase I...Diana M Fridlyand, Shanmuganathan Chandrakasan, Ahmed Aljudi, Waitman K Aumann, Eleanor Westfall, Bailey Kirwan, Elyse W Bryson, Frank G Keller, Staci D Arnold, Andrew...> ;Journal of Pediatric Hematology/oncology. 2023 Jan 1
- 3 citationsComprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.Ryan J Summers, Sharon M Castellino, Christopher C Porter, Tobey J MacDonald, Gargi D Basu, Szabolcs Szelinger, Manoj K Bhasin, Thomas Cash, Alexis B Carter, Robert Cr...> ;JCO Precision Oncology. 2022 Apr 1
- Join now to see all
Abstracts/Posters
- Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)Melinda Pauly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Children’s Healthcare of Atlanta Opens First Clinical Trial for New Therapy Targeting LeukemiaApril 12th, 2023
Hospital Affiliations
Emory University HospitalAtlanta, Georgia
Childrens Healthcare of Atlanta at Scottish RiteAtlanta, Georgia
Children's Healthcare of AtlantaAtlanta, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
